DA VOLTERRA
SME
DA VOLTERRA
Description
DA VOLTERRA develops investigational therapies designed for the treatment of intestinal microbiome dysbiosis in cancer patients.
DA VOLTERRA
Address
172 RUE DE CHARONNE PARIS 75011 FRANCE
PARIS, FRANCE
PARIS, FRANCE
Contact
press@davolterra.com
Description
DA VOLTERRA develops investigational therapies designed for the treatment of intestinal microbiome dysbiosis in cancer patients.
Matchmaking
Connect with DA VOLTERRA
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways